Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP348235.RA1rzTfkRX3tBpcoRgCI219XjQ9u-grannw3dyhTbXWxw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP348235.RA1rzTfkRX3tBpcoRgCI219XjQ9u-grannw3dyhTbXWxw130_assertion type Assertion NP348235.RA1rzTfkRX3tBpcoRgCI219XjQ9u-grannw3dyhTbXWxw130_head.
- NP348235.RA1rzTfkRX3tBpcoRgCI219XjQ9u-grannw3dyhTbXWxw130_assertion wasGeneratedBy ECO_0000203 NP348235.RA1rzTfkRX3tBpcoRgCI219XjQ9u-grannw3dyhTbXWxw130_provenance.
- NP348235.RA1rzTfkRX3tBpcoRgCI219XjQ9u-grannw3dyhTbXWxw130_assertion wasDerivedFrom befree-2016 NP348235.RA1rzTfkRX3tBpcoRgCI219XjQ9u-grannw3dyhTbXWxw130_provenance.
- NP348235.RA1rzTfkRX3tBpcoRgCI219XjQ9u-grannw3dyhTbXWxw130_assertion SIO_000772 11896121 NP348235.RA1rzTfkRX3tBpcoRgCI219XjQ9u-grannw3dyhTbXWxw130_provenance.
- NP348235.RA1rzTfkRX3tBpcoRgCI219XjQ9u-grannw3dyhTbXWxw130_assertion evidence source_evidence_literature NP348235.RA1rzTfkRX3tBpcoRgCI219XjQ9u-grannw3dyhTbXWxw130_provenance.
- NP348235.RA1rzTfkRX3tBpcoRgCI219XjQ9u-grannw3dyhTbXWxw130_assertion description "[Four tyrosine kinase inhibitors that have activity against KIT are currently being used in clinical trials, and one, STI571, has recently been approved by the United States Food and Drug Administration for treating patients with chronic myelogenous leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP348235.RA1rzTfkRX3tBpcoRgCI219XjQ9u-grannw3dyhTbXWxw130_provenance.